Apoptosis and P53 in inverting papilloma of the sinonasal tract

American Journal of Rhinology

Volumn 13, Issue 6, 1999, Pages 427-434

  Mirza, Natasha ^a,b   Nofsinger, Yoon Choi ^a,b   Kroger, Hans ^a,b   Sato, Yuich ^a,b   Furth, Emma Elizabeth ^a,b   Montone, Kathleen T ^a,b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b Columbia University School of Public Health ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

APOPTOSIS; ARTICLE; COMPARATIVE STUDY; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; INVERTED PAPILLOMA; MALE; NEEDLE BIOPSY; NOSE TUMOR; PATHOLOGY; REFERENCE VALUE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR GENE;

APOPTOSIS; BIOPSY, NEEDLE; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NOSE NEOPLASMS; PAPILLOMA, INVERTED; REFERENCE VALUES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0033218623     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/105065899781329737     Document Type: Article

References (30)

1. Snyder RN, Puzim KH. Papillomatosis of nasal cavity and paranasal sinuses. Cancer 30:668-669, 1972.
2. Esclamado RM. Squamous cell carcinoma arising in inverted papilloma. Laryngoscope 105:178-183, 1995.
3. 3 Stern MC, Duran HA, McKenna EA, Conti CJ. Increased apoptosis during papilloma development in mice susceptible to tumor progression. Mol Carcinog 20:137-142, 1997.
4. Masahiro A, Truong LD, Dunn JK, et al. Frequency of apoptotic bodies positively correlates with Gleason Grade in prostate cancer. Hum Pathol 25:797-801, 1994.
5. Lowe SW, Schmidt EM, Smith SW. et al. P53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849, 1993.
6. Agarwal R, Korman NJ, Mohan RR, et al. Apoptosis is an early event during phalocyanine photodynamic therapy-induced ablation of chemically induced squamous papillomas in mouse skin. Photochem Photobiol 63:547-552, 1996.
7. Thompson HJ, Strange R, Schedin PJ. Apoptosis in the genesis and prevention of cancer. Cancer Epidemiol Biomark Prev 1:597-602, 1992.
8. Xu C, Meikrantz W, Schlegel R, Sager R. The human papilloma virus 16 E6 gene sensitize human mammary epithelial cells to apoptosis-induced by DNA damage. Proc Natl Acad Sci USA 92:7829-7833, 1995.
9. Wijsman JH, Jonker RR, Keijzer R, von de Velde CJ, et al. A new method to detect apoptosis in paraffin sections: In situ end labeling of fragmented DNA. J Histochemistry Cytochemistry 41:7-12, 1993.
10. Felgar RE. Furth EE, Wastik MA, et al. Histiocytic necrotizing lymphadenitis in (Kickuchi's disease): In situ end labeling immunohistochemical and serologic evidence supporting cytotoxic lymphocyte-mediated apoptotic cell death. Mod Pathol 10:231-241, 1997.
11. Wang JY, Montone KT. A rapid simple in-situ hybridization method for herpes simplex virus employing a synthetic biotin labeled oligonucleotideprobe. A comparison with immunohistochemical methods for HSV detection. J Clin Lab Anal 8:105-115, 1994.
12. Vaux D. Toward an understanding of the molecular mechanisms of physiologic cell death. Proc Natl Acad Sci USA 90:786-789, 1993.
13. Hagari Y, Budgeon LR, Pickel MD, Kreider JW. Association of tumor necrosis factor-alpha gene expression and apoptotic cell death with regression of shope papillomas. J Invest Dermatol 104:526-529, 1995.
14. 14 Wright SC, Zhong J, Larrick JW. Inhibition of apoptosis as a mechanism of tumor promotion. FASEB J 8:654-660, 1994.
15. Sheets EE, Crum CP, Yah J. Association between cervical neoplasia and apoptosis as detected by in situ nuclear labeling. Gynecol Oncol 63:94-100, 1996.
16. Arai T, Kino I. Modulation of apoptosis in modulation of the growth of human colorectal tubular and villous adenomas. J Pathol 176:37-44, 1995.
17. Saegusa M, Takano Y, Wakabayashi T, Okayasu I. Apoptosis in gastric carcinomas and its association with cell proliferation and differentiation. JPN J Cancer Res 86:743-748, 1995.
18. Silvestri F, Bussani, R, Pavletic N, et al. From epithelial dysplasia to squamous cell carcinoma of the head and neck region. Evolutive and prognostic histopathological markers. Acta Otolaryngol (Stockh) Suppl 527:49-51, 1997.
19. Birchall M, Winterford C, Tripconi L, et al. Apoptosis and mitosis in oral and oropharyngeal epithelia: Evidence for a total graphic switch in premalignant lesions. Cell Prolif 29:447-456, 1996.
20. Montironi R, Magi-Galluzzi C, Fabris G. Apoptotic bodies in prostatic intraepithelial neoplasia and prostatic adenocarcinoma following total androgen ablation. Path Res Pract 191:873-888, 1995.
21. Schuhe-Hermann R, Grasl-Kraupp B, Bursch W. Tumor development and apoptosis. Int Arch Allergy Immunology 105:363-336, 1994.
22. Duvall E, Wyllie AH. Death and the cell. Immunol Today 7:115-119, 1986.
23. Arends MJ, Wyllie AH Apoptosis. Mechanisms and roles in pathology. Int Rev Exp Pathol 32:223-254, 1991.
24. Green DR, Martin SJ. The killer and the executioner: How apoptosis controls malignancy. Cancer 7:694-703, 1995.
25. Prescott DM. Cell reproduction. Int Rev Cytol 100:93-128, 1987.
26. Blank KR, Rudoltz MS, Kao CD, et al. The molecular regulation of apoptosis and implications for radiation oncology. Int J Radiat Biol 71:455-466, 1997.
27. Lowe SW, Ruley HE, Jacks T, Housman DE. P53-dependent apoptosis modulates the cytotoxicity of anticancer drugs. Cell 74:954-967, 1993.
28. Mirza, N, Montone K, Sato Y, et al. Identification of p53 and human papilloma virus in Schneiderian papillomas. Laryngoscope 108:497-501, 1998.
29. Shoji Y, Saegusa M, Takano Y, et al. Correlation of apoptosis with tumor cell differentiation, progression, and HPV infection in cervical carcinoma. J Clin Pathol 49:134-138, 1996.
30. Yonish Rouach E, Resnitzky D, Lotem J, et al. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by Interleukin-6. Nature 352:345-347, 1991.